Clinical Isolates of Uncomplicated Falciparum Malaria from High and Low Malaria Transmission Areas Show Distinct Pfcrt and Pfmdr1 Polymorphisms in Western Ethiopia

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2023 Jun 3

PMID 37270589

Authors

Geletta Tadele

Aminata Jawara

Mary Oboh

Eniyou Oriero

Sisay Dugassa

Alfred Amambua-Ngwa

Lemu Golassa

Affiliations

Soon will be listed here.

Abstract

Background: Pfcrt gene has been associated with chloroquine resistance and the pfmdr1 gene can alter malaria parasite susceptibility to lumefantrine, mefloquine, and chloroquine. In the absence of chloroquine (CQ) and extensive use of artemether-lumefantrine (AL) from 2004 to 2020 to treat uncomplicated falciparum malaria, pfcrt haplotype, and pfmdr1 single nucleotide polymorphisms (SNPs) were determined in two sites of West Ethiopia with a gradient of malaria transmission.

Methods: 230 microscopically confirmed P. falciparum isolates were collected from Assosa (high transmission area) and Gida Ayana (low transmission area) sites, of which 225 of them tested positive by PCR. High-Resolution Melting Assay (HRM) was used to determine the prevalence of pfcrt haplotypes and pfmdr1 SNPs. Furthermore, the pfmdr1 gene copy number (CNV) was determined using real-time PCR. A P-value of less or equal to 0.05 was considered significant.

Results: Of the 225 samples, 95.5%, 94.4%, 86.7%, 91.1%, and 94.2% were successfully genotyped with HRM for pfcrt haplotype, pfmdr1-86, pfmdr1-184, pfmdr1-1042 and pfmdr1-1246, respectively. The mutant pfcrt haplotypes were detected among 33.5% (52/155) and 80% (48/60) of isolates collected from the Assosa and Gida Ayana sites, respectively. Plasmodium falciparum with chloroquine-resistant haplotypes was more prevalent in the Gida Ayana area compared with the Assosa area (COR = 8.4, P = 0.00). Pfmdr1-N86Y wild type and 184F mutations were found in 79.8% (166/208) and 73.4% (146/199) samples, respectively. No single mutation was observed at the pfmdr1-1042 locus; however, 89.6% (190/212) of parasites in West Ethiopia carry the wild-type D1246Y variants. Eight pfmdr1 haplotypes at codons N86Y-Y184F-D1246Y were identified with the dominant NFD 61% (122/200). There was no difference in the distribution of pfmdr1 SNPs, haplotypes, and CNV between the two study sites (P > 0.05).

Conclusion: Plasmodium falciparum with the pfcrt wild-type haplotype was prevalent in high malaria transmission site than in low transmission area. The NFD haplotype was the predominant haplotype of the N86Y-Y184F-D1246Y. A continuous investigation is needed to closely monitor the changes in the pfmdr1 SNPs, which are associated with the selection of parasite populations by ACT.

Citing Articles

Mapping Antimalarial Drug Resistance in Mozambique: A Systematic Review of Genetic Markers Post-ACT Implementation.

Chaves C, Da Silva C, Salamandane A, Nogueira F Int J Mol Sci. 2025; 25(24.

PMID: 39769406 PMC: 11728251. DOI: 10.3390/ijms252413645.

Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey.

Avci K, Karakus M, Yasar K Malar J. 2024; 23(1):286.

PMID: 39334180 PMC: 11437951. DOI: 10.1186/s12936-024-05107-6.

References

Achieng A, Muiruri P, Ingasia L, Opot B, Juma D, Yeda R . Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Int J Parasitol Drugs Drug Resist. 2015; 5(3):92-9. PMC: 4501530. DOI: 10.1016/j.ijpddr.2015.05.005. View

Heuchert A, Abduselam N, Zeynudin A, Eshetu T, Loscher T, Wieser A . Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013. Malar J. 2015; 14:208. PMC: 4490604. DOI: 10.1186/s12936-015-0723-2. View

Arya A, Kojom Foko L, Chaudhry S, Sharma A, Singh V . Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions - India and sub-Saharan Africa. Int J Parasitol Drugs Drug Resist. 2021; 15:43-56. PMC: 7887327. DOI: 10.1016/j.ijpddr.2020.11.006. View

Al-Mekhlafi H, Madkhali A, Abdulhaq A, Atroosh W, Ghzwani A, Zain K . Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia. Sci Rep. 2022; 12(1):517. PMC: 8752599. DOI: 10.1038/s41598-021-04450-x. View

Qidwai T . Exploration of copy number variation in genes related to anti-malarial drug resistance in Plasmodium falciparum. Gene. 2020; 736:144414. DOI: 10.1016/j.gene.2020.144414. View

Kublin J, Cortese J, Njunju E, Mukadam R, Wirima J, Kazembe P . Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003; 187(12):1870-5. DOI: 10.1086/375419. View

Sidhu A, Valderramos S, Fidock D . pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol. 2005; 57(4):913-26. DOI: 10.1111/j.1365-2958.2005.04729.x. View

Tumwebaze P, Conrad M, Okitwi M, Orena S, Byaruhanga O, Katairo T . Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022; 13(1):6353. PMC: 9605985. DOI: 10.1038/s41467-022-33873-x. View

Awasthi G, Satya Prasad G, Satya G, Das A . Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Mem Inst Oswaldo Cruz. 2012; 107(1):129-34. DOI: 10.1590/s0074-02762012000100018. View

10.

Schunk M, Kumma W, Barreto Miranda I, Osman M, Roewer S, Alano A . High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia. Malar J. 2006; 5:54. PMC: 1524791. DOI: 10.1186/1475-2875-5-54. View

11.

Roux A, Maharaj L, Oyegoke O, Akoniyon O, Adeleke M, Maharaj R . Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Sub-Saharan Africa-A Review. Front Genet. 2021; 12:668574. PMC: 8267899. DOI: 10.3389/fgene.2021.668574. View

12.

Voumbo-Matoumona D, Kouna L, Madamet M, Maghendji-Nzondo S, Pradines B, Lekana-Douki J . Prevalence of antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014. Infect Drug Resist. 2018; 11:1329-1338. PMC: 6118251. DOI: 10.2147/IDR.S160164. View

13.

Hofmann N, Mwingira F, Shekalaghe S, Robinson L, Mueller I, Felger I . Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015; 12(3):e1001788. PMC: 4348198. DOI: 10.1371/journal.pmed.1001788. View

14.

Veiga M, Dhingra S, Henrich P, Straimer J, Gnadig N, Uhlemann A . Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016; 7:11553. PMC: 4873939. DOI: 10.1038/ncomms11553. View

15.

Gadalla N, Adam I, Elzaki S, Bashir S, Mukhtar I, Oguike M . Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother. 2011; 55(11):5408-11. PMC: 3195064. DOI: 10.1128/AAC.05102-11. View

16.

Pelleau S, Moss E, Dhingra S, Volney B, Casteras J, Gabryszewski S . Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci U S A. 2015; 112(37):11672-7. PMC: 4577156. DOI: 10.1073/pnas.1507142112. View

17.

Menard D, Dondorp A . Antimalarial Drug Resistance: A Threat to Malaria Elimination. Cold Spring Harb Perspect Med. 2017; 7(7). PMC: 5495053. DOI: 10.1101/cshperspect.a025619. View

18.

Uwimana A, Legrand E, Stokes B, Ndikumana J, Warsame M, Umulisa N . Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020; 26(10):1602-1608. PMC: 7541349. DOI: 10.1038/s41591-020-1005-2. View

19.

Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G . High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia. Malar J. 2014; 13:120. PMC: 3986696. DOI: 10.1186/1475-2875-13-120. View

20.

Gresty K, Gray K, Bobogare A, Taleo G, Hii J, Wini L . Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands. Malar J. 2014; 13:406. PMC: 4210516. DOI: 10.1186/1475-2875-13-406. View